Gut microbiota and metabolic-associated steatosis liver disease: Unveiling mechanisms and opportunities for therapeutic intervention
Resha Dermawansyah Rusman, Fardah Akil, Muhammad Luthfi Parewangi, Nu'man AS Daud, Rini Bachtiar, Susanto Hendra Kusuma, Amelia Rifai · 2025
Read Gut microbiota and metabolic-associated steatosis liver disease: Unveiling mechanisms and opportunities for therapeutic intervention by Resha Dermawansyah Rusman, Fardah Akil, Muhammad Luthfi Parewangi, Nu'man AS Daud, Rini Bachtiar, Susanto Hendra Kusuma, Amelia Rifai (2025) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-12767250.txt.
Description
Resha Dermawansyah Rusman and co-authors review work from two thousand twenty-five on gut microbes and fatty liver disease tied to metabolic problems. The disease, shortened to MASLD, is now a leading cause of chronic liver trouble. Evidence points to the gut-liver axis, the two-way traffic between intestine and liver, as a major driver.
When gut microbes fall out of balance, the gut wall leaks and bacterial toxins reach the liver, fueling inflammation, insulin resistance, and scarring. Microbe products such as short-chain fatty acids and bile acids also steer host metabolism. The review covers treatments aimed at microbes, from probiotics and diet change to stool transfer. Results vary by person, so the authors stress tailored care and clearer definitions.
Catalog record
| CREATOR | Resha Dermawansyah Rusman, Fardah Akil, Muhammad Luthfi Parewangi, Nu'man AS Daud, Rini Bachtiar, Susanto Hendra Kusuma, Amelia Rifai |
|---|---|
| YEAR | 2025 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 38 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |